Dan Harma
About Dan Harma
Dan Harma serves as the Chief Commercial Officer at Pillar Biosciences, where he focuses on enhancing global access to oncology diagnostics. With over 25 years of experience in commercial leadership roles within the diagnostics industry, he has held various positions at Abbott Diagnostics and NeuMoDx Molecular.
Current Role at Pillar Biosciences
Dan Harma serves as the Chief Commercial Officer (CCO) at Pillar Biosciences Incorporated, a role he has held since 2022. In this position, he is responsible for expanding accessibility to oncology diagnostics on a global scale. His leadership focuses on enhancing commercial strategies and driving growth within the organization.
Previous Experience at Abbott Diagnostics
Dan Harma has extensive experience at Abbott Diagnostics, where he held multiple leadership positions. He served as General Manager for ADD Canada from 2007 to 2011, Managing Director for the West Region US from 2015 to 2017, and Director of Enterprise Accounts from 2011 to 2015. Additionally, he worked as Senior Director of Commercial Operations for the US and Canada from 2004 to 2007.
Background in Commercial Leadership
With over 25 years of experience in commercial leadership roles within the diagnostics industry, Dan Harma has developed a strong reputation for his ability to hire, develop, and lead high-performing commercial organizations. His background includes a role at NeuMoDx Molecular prior to joining Pillar Biosciences, where he further honed his skills in the diagnostics sector.
Education and Qualifications
Dan Harma holds a Master of Business Administration (MBA) from the Quinlan School of Business at Loyola University Chicago. He also earned a Bachelor of Business Administration (BBA) in Marketing from the University of Wisconsin-Whitewater, where he studied from 1984 to 1988.